Humans and genetically engineered mice with
hypobetalipoproteinemia due to truncation-producing mutations of the
apolipoprotein B (
apoB) gene frequently have fatty livers, because the
apoB defect impairs the capacity of livers to export
triglycerides (TGs). We assessed the adaptation of hepatic lipid metabolism in our apoB-38.9-bearing mice. Hepatic TG contents were 2- and 4-fold higher in heterozygous and homozygous mice, respectively, compared with wild-type mice. Respective in vivo hepatic
fatty acid synthetic rates were reduced to 40% and 15% of the wild-type rate. Hepatic mRNAs for
sterol regulatory element-binding protein (SREBP)-1c,
fatty acid synthase (FAS), and
stearoyl coenzyme A desaturase-1 were coordinately decreased. FAS and
SREBP-1c mRNA levels were strongly and positively correlated with each other and inversely correlated with hepatic TGs, suggesting that impaired TG export is a potent inhibitor of
fatty acid synthesis. In contrast, levels of plasma
beta-hydroxybutyrate and of hepatic
carnitine palmitoyl
transferase and
peroxisome proliferator-activated receptor-alpha mRNAs were not altered, implying that beta-oxidation was not affected. Fasting followed by refeeding increased hepatic
fatty acid synthesis 56-fold over fasting in normal and heterozygous mice but only 24-fold in homozygous mice. Parallel changes occurred in FAS and
SREBP-1c mRNAs. Thus, impairment of
very low density lipoprotein export downregulates hepatic
fatty acid synthesis, but the adaptation is incomplete, resulting in fatty livers. The signals mediating suppression of FAS and
SREBP-1c levels remain to be identified.